These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Therapeutic application of calcium-channel antagonists for pulmonary hypertension. Packer M Am J Cardiol; 1985 Jan; 55(3):196B-201B. PubMed ID: 3881914 [TBL] [Abstract][Full Text] [Related]
27. Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension. Diamond JA; Krakoff LR; Goldman A; Coplan N; Gharavi A; Martin K; Goldsmith R; Henzlova MJ; Machac J; Phillips RA Am J Hypertens; 2001 Mar; 14(3):231-40. PubMed ID: 11281234 [TBL] [Abstract][Full Text] [Related]
28. Experience with calcium antagonist drugs in congestive heart failure. O'Rourke RA; Walsh RA Am J Cardiol; 1987 Jan; 59(3):64B-69B. PubMed ID: 3812267 [TBL] [Abstract][Full Text] [Related]
29. The effects of calcium channel blocking agents on cardiovascular function. Low RI; Takeda P; Mason DT; DeMaria AN Am J Cardiol; 1982 Feb; 49(3):547-53. PubMed ID: 7058766 [TBL] [Abstract][Full Text] [Related]
30. Calcium antagonists and chronic cardiac failure. Kendall MJ; Horton RC; Smith SR Postgrad Med J; 1986 Aug; 62(730):713-7. PubMed ID: 3534840 [No Abstract] [Full Text] [Related]
31. Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure. Su J; Renaud N; Carayon A; Crozatier B; Hittinger L Br J Pharmacol; 1994 Oct; 113(2):395-402. PubMed ID: 7834190 [TBL] [Abstract][Full Text] [Related]
32. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure. Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627 [TBL] [Abstract][Full Text] [Related]
33. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. Ishikawa K; Nakai S; Takenaka T; Kanamasa K; Hama J; Ogawa I; Yamamoto T; Oyaizu M; Kimura A; Yamamoto K; Yabushita H; Katori R Circulation; 1997 May; 95(10):2368-73. PubMed ID: 9170398 [TBL] [Abstract][Full Text] [Related]
34. Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem, and verapamil. Gassner A; Sommer G; Fridrich L; Magometschnigg D; Priol A Chest; 1990 Oct; 98(4):829-34. PubMed ID: 2209138 [TBL] [Abstract][Full Text] [Related]
35. [The effect of calcium antagonists on the hemodynamic function in patients with heart failure]. Gorb IuG; Seab KhK; Mikliaev IIu Vrach Delo; 1990 Jul; (7):19-21. PubMed ID: 2238587 [TBL] [Abstract][Full Text] [Related]
36. [Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction]. Sakai M; Ueda K; Nakahara K; Tsuchimochi H; Mutsushita S; Kuramoto K; Murakami M Kokyu To Junkan; 1985 Feb; 33(2):159-64. PubMed ID: 4001593 [No Abstract] [Full Text] [Related]
37. [Verapamil, diltiazem or nifedipine in severe left ventricular functional disorder? A comparative study of the immediate hemodynamic effects]. Figulla HR; Kreuzer H; Luig H Dtsch Med Wochenschr; 1986 Jan; 111(1):11-4. PubMed ID: 3940829 [TBL] [Abstract][Full Text] [Related]
38. Use of calcium antagonists to treat heart failure. Conti CR Clin Cardiol; 1994 Mar; 17(3):101-2. PubMed ID: 7909507 [TBL] [Abstract][Full Text] [Related]
39. Current status of calcium channel blocking drugs after myocardial infarction. Moss AJ Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237 [TBL] [Abstract][Full Text] [Related]
40. [Calcium antagonists in arterial hypertension]. Muiesan G G Ital Cardiol; 1988 Nov; 18(11):982-8. PubMed ID: 3073993 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]